Pathways to smoking behaviours: biological insights from the Tobacco and Genetics Consortium meta-analysis.
- Authors
- Minicã, C C; Mbarek, H; Pool, R; Dolan, C V; Boomsma, D I; Vink, J M
- Year
- 2017
- Journal
- Molecular psychiatry
- PMID
- 27021816
- DOI
- 10.1038/mp.2016.20
- PMCID
- PMC5777181
By running gene and pathway analyses for several smoking behaviours in the Tobacco and Genetics Consortium (TAG) sample of 74 053 individuals, 21 genes and several chains of biological pathways were implicated. Analyses were carried out using the HYbrid Set-based Test (HYST) as implemented in the Knowledge-based mining system for Genome-wide Genetic studies software. Fifteen genes are novel and were not detected with the single nucleotide polymorphism-based approach in the original TAG analysis. For quantity smoked, 14 genes passed the false discovery rate of 0.05 (corrected for multiple testing), with the top association signal located at the IREB2 gene (P=1.57E-37). Three genomic loci were significantly associated with ever smoked. The top signal is located at the noncoding antisense RNA transcript BDNF-AS (P=6.25E-07) on 11p14. The SLC25A21 gene (P=2.09E-08) yielded the top association signal in the analysis of smoking cessation. The 19q13 noncoding RNA locus exceeded the genome-wide significance in the analysis of age at initiation (P=1.33E-06). Pathways belonging to the Neuronal system pathways, harbouring the nicotinic acetylcholine receptor genes expressing the α (CHRNA 1-9), β (CHRNB 1-4), γ, δ and ɛ subunits, yielded the smallest P-values in the pathway analysis of the quantity smoked (lowest P=4.90E-42). Additionally, pathways belonging to 'a subway map of cancer pathways' regulating the cell cycle, mitotic DNA replication, axon growth and synaptic plasticity were found significantly enriched for genetic variants in ever smokers relative to never smokers (lowest P=1.61E-07). In addition, these pathways were also significantly associated with the quantity smoked (lowest P=4.28E-17). Our results shed light on one of the world's leading causes of preventable death and open a path to potential therapeutic targets. These results are informative in decoding the biological bases of other disease traits, such as depression and cancers, with which smoking shares genetic vulnerabilities.
No figures extracted from this document.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| The genetic epidemiology of substance use disorder: A review. | 2017 | 28938182 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Impact of miR-29c-3p in the Nucleus Accumbens on Methamphetamine-Induced Behavioral Sensitization and Neuroplasticity-Related Proteins. | Su H et al. | — | 2024 | → |
| An in-depth association analysis of genetic variants within nicotine-related loci: Meeting in middle of GWAS and genetic fine-mapping. | Mo C et al. | — | 2023 | → |
| Evaluating the causal effect of tobacco smoking on white matter brain aging: a two-sample Mendelian randomization analysis in UK Biobank. | Mo C et al. | — | 2023 | → |
| Genetic Variants Associated with Supernormal Coronary Arteries. | Kim B et al. | — | 2023 | → |
| Behavioral and Genetic Factors Associated with Successful Long-Term Cessation in Persons with HIV Who Smoke Cigarettes. | Shuter J et al. | — | 2021 | → |
| Cholinergic receptor nicotinic beta 3 subunit polymorphisms and smoking in male Chinese patients with schizophrenia. | Shi J et al. | — | 2021 | → |
| Gene-based association analysis reveals involvement of LAMA5 and cell adhesion pathways in nicotine dependence in African- and European-American samples. | Fan R et al. | — | 2021 | → |
| Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent. | Buchwald J et al. | — | 2021 | → |
| New and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis. | Choquet H et al. | — | 2021 | → |
| Genetic Fine-mapping with Dense Linkage Disequilibrium Blocks: genetics of nicotine dependence | Mo C et al. | — | 2020 | — |
| Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial. | Chen LS et al. | — | 2020 | → |
| Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. | Chen J et al. | — | 2020 | → |
| Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors. | Ma Y et al. | — | 2020 | → |
| Interactions between monoamine oxidase A rs1137070 and smoking on brain structure and function in male smokers. | Shen Z et al. | — | 2019 | → |
| Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Focus on Mutations - Part 1. | Russo P et al. | — | 2019 | → |
| Transcriptomic Characterization of the Human Insular Cortex and Claustrum. | Ibrahim C et al. | — | 2019 | → |
| Transcriptomic Characterization of the Human Habenula Highlights Drug Metabolism and the Neuroimmune System. | Le Foll B et al. | — | 2018 | → |
| A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems. | Richmond-Rakerd LS et al. | — | 2017 | → |
| Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments. | Sakata K et al. | — | 2017 | → |
| snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma. | Nogueira Jorge NA et al. | — | 2017 | → |
| The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations. | Barrie ES et al. | — | 2017 | → |
| The genetic epidemiology of substance use disorder: A review. | Prom-Wormley EC et al. | — | 2017 | → |